Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT07441629 Sponsor: University Hospital, Grenoble Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT07441629
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 18 years of age or older.
  • People who have a confirmed diagnosis of Crohn's disease.
  • People whose Crohn's disease involves narrowing or blockages in the bowel (known as a stricturing form), confirmed through clinical assessment, a camera procedure, imaging, or surgery.
  • People who are being cared for in a hospital department that specialises in inflammatory bowel diseases.
  • People who are in a stable phase of their illness at the time of the interview — meaning they are not currently experiencing a severe flare-up that requires urgent hospital care.
  • People who are able to understand and speak French, as the trial involves a qualitative interview conducted in French.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently hospitalised due to a severe Crohn's disease flare-up, a serious bowel blockage, or any other situation requiring urgent medical care.
  • People who have significant difficulties with thinking, communication, or have an acute psychiatric condition that would prevent them from understanding the interview or expressing their experiences reliably.
  • People with a serious uncontrolled medical condition — such as active cancer currently being treated, or severe heart failure — that would make participation in an interview unsuitable (confirm with trial site).
  • People who are unable to take part in an interview due to practical reasons — for example, being unable to travel to the interview location and having no access to videoconference if a remote interview is required.
  • People who are pregnant.
  • People who are currently detained or deprived of their liberty.
  • People who are currently receiving psychiatric care.
  • People who are currently admitted to a healthcare or social care institution.
  • People who are subject to a legal protection measure (confirm with trial site).
  • People who are unable to give their consent to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 4 76 76 86 41

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
1 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Frequency of patient-reported symptom categories associated with stenosing Crohn's disease, derived from thematic content analysis of single semi-structured interviews.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov